Product Description: Zanolimumab (Anti-Human CD4 Recombinant Antibody) is a fully human monoclonal antibody targets CD4. Zanolimumab effectively inhibits T-cell receptor (TCR) signal transduction. Zanolimumab can be used for the research of heumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Rider DA, et al. A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity. Cancer Res. 2007 Oct 15;67(20):9945-53.
CAS Number: 652153-01-0
Molecular Weight: N/A
Compound Purity: 99.21
Research Area: Cancer; Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Others